Videos

Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis

Featuring Ronald Vender, MD, FRCPC

07/13/2023

In this exclusive interview with The Dermatologist, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis following his study, “Viewpoint About Biologic Agents for Psoriasis: Are They Immunosuppressants or Immunomodulators?”

Ronald Vender, MD, FRCPC, is the founder and director of Dermatrials Research Incorporated and Venderm Consulting in Hamilton, ON, Canada. He is also an associate clinical professor at McMaster University in the department of medicine, division of dermatology.

Transcript to Come

© 2023 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.

Current Issue

August 2024

Volume 32

Issue 5

Current Issue

Issue Archive

Popular Articles

Biologics in Practice

Patient Education for Biologic Therapy of Psoriasis and Psoriatic Arthritis

07/09/2012

Properly educating patients about the benefits and risks of biologic therapy can lead to significant improvements in the symptoms of psoriasis and patient satisfaction.

Properly educating patients...

07/09/2012

The Dermatologist

Podcasts

Dr Rosen on STDs During the Pandemic

12/22/2020

In this podcast, Ted Rosen, MD, reviews the diagnosis and management of sexually transmitted diseases for dermatologists, as well as how the pandemic has impacted patients with STDs.

In this podcast, Ted Rosen, MD,...

12/22/2020

The Dermatologist

Biologics in Practice

Immunopathogenesis of Psoriasis and Mechanism of Biologics

04/09/2012

A review of the current understanding of the immunologic basis of psoriasis pathogenesis and the mechanisms by which biologic medications target disease.

A review of the current...

04/09/2012

The Dermatologist

Feature Story

Redefining Our Risk Tolerance During “Reentry” in the COVID-19 Era

06/17/2021

Richard Fried, MD, PhD

Another shift from the pandemic was personal definitions of risk tolerance in terms of health safety. It is once again time to consider redefining what risk tolerance means as public health intiatives move us past the pandemic.

Another shift from the pandemic...

06/17/2021

The Dermatologist

Spotlight

Spotlight On: Nathaniel Jellinek, MD, FAAD, FACMS

12/07/2011

This month`s interview is with Nathaniel Jellinek, MD, FAAD, FACMS, who is in private practice and whose academic interests include nail diseases, nail surgery, cutaneous oncology, facial reconstruction and dermatologic education.

This month`s interview is with...

12/07/2011

The Dermatologist

The Dermatologist Newsletter

Latest Quizzes and Trivia

Quiz

QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis

08/10/2024

Riya Gandhi , MA;

What strategies did Dr Merola emphasize for atopic dermatitis?

What strategies did Dr Merola...

08/10/2024

The Dermatologist

contact dermtitis + Neck + Eczema + rash

Quiz

QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing

07/14/2024

What is a common challenge for patients during the patch testing week?

What is a common challenge for...

07/14/2024

The Dermatologist

Quiz

Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis

05/30/2024

Riya Gandhi, MA, Associate Editor

According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?

According to a recent interview...

05/30/2024

The Dermatologist

Quiz

Quiz: Atopic Dermatitis Spotlight

05/06/2024

Riya Gandhi, MA, Associate Editor

Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?

Which class of medications...

05/06/2024

The Dermatologist

Quiz

True or False: Basal Cell Carcinoma on Vermilion Lip

05/01/2024

Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?

Is basal cell carcinoma on the...

05/01/2024

The Dermatologist

Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee

Quiz

Quiz: Navigating New Therapies in Atopic Dermatitis

04/10/2024

Riya Gandhi, MA, Associate Editor

In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?

In a recent interview, Dr...

04/10/2024

The Dermatologist

Quiz

Trivia: Atopic Dermatitis Patients With Alopecia Areata

02/28/2024

Riya Gandhi, MA, Associate Editor

02/28/2024

The Dermatologist

Quiz

Trivia: Itch Cycle and OTC Products

12/27/2023

The Dermatologist

Quiz

12/20/2023

Jessica Garlewicz, Digital Managing Editor

When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?

When treating mild to moderate...

12/20/2023

The Dermatologist

Quiz

Dupilumab Mechanism of Action

11/07/2023

Jessica Garlewicz, Digital Managing Editor

According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?

According to a recent interview...

11/07/2023

The Dermatologist

Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis

© 2023 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.

Current Issue

Popular Articles

Subscribe

Latest Quizzes and Trivia

Specialties

Events

Year Round Education

HMP Global Products